Abstract:In effort s to achieve minimal systemic toxicity and high tumor delivery efficiencies in cancer therapy, various nanomedicine formulations having stealth polymer coatings have been developed for minimizing immune cell uptake and off-target macrophage phagocyte system (MPS) organ accumulation. Despite an initial reduction in immune cell uptake, stealth nanoparticles still initiate an antibody immune response. This response acts on subsequent administrations in treatment regimens resulting in accelerated blood clearance of particles into MPS organs, particularly the liver, where they are retained for prolonged periods. Consequently, doses after the first administration in treatment regimens have diminished tumor accumulation and increased MPS toxicity. Here, we present a strategy reducing antibody responses to each dose in a treatment regimen by alternating between polyethylene-glycol and polymethyloxazoline polymers as the nanoparticle coating between administrations. In a weekly dosing regimen, we find that the first dose of particles having either coating display similar favorable pharmacokinetics and biodistributions, thus allowing the polymers to be used interchangeably. However, when maintaining the same coating in subsequent administrations, we find that particles are in circulation at the height of the antibody immune response resulting in 50-60% decreases of circulation half-lives and tumor accumulation along with 50% increases in liver accumulation. By alternating the polymers used in the nanoparticle coating between administrations, we find each dose maintains favorable in vivo behaviors at the height of the antibody immune response to the previous administration. Furthermore, our strategy increases the clearance of particles uptaken by macrophages and hepatocytes, resulting in marked decreases in hepatotoxicity. Statement of significance While nanoparticles with coatings consisting of stealth polymers can minimize immune cell uptake, they still initiate antibody immune responses leading to rapid blood clearance and MPS sequestration of subsequent administrations within a treatment regimen. We demonstrate that by alternating PEG and PMOZ polymer coatings between weekly administrations, the antibody immune response acting on each administration is minimal, and the favorable in vivo behaviors observed with the first administration is maintained in subsequent administrations. In this case, greater tumor accumulation is achieved while curtailing excessive MPS organ accumulation and toxicity throughout a nanomedicine treatment. We envision our strategy will benefit clinical trials where frequent administrations of therapeutics are required or in sequential deliveries of prognostic and therapeutic agents. (c) 2021 Published by Elsevier Ltd on behalf of Acta Materialia Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

Oxidation-Sensitive Dextran-Based Polymer with Improved Processability through Stable Boronic Ester Groups.

Dextran-based thermo-responsive hemoglobin–polymer conjugates with oxygen-carrying capacity

Oxidation-Sensitive Polymersomes Based on Amphiphilic Diblock Copolypeptoids.

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Immunotheranostic Polymersomes Modularly Assembled from Tetrablock and Diblock Copolymers with Oxidation-Responsive Fluorescence

Oxidation-Accelerated Hydrolysis of the Ortho Ester-Containing Acid-Labile Polymers

Oxidation Responsive PEGylated Polyamino Acid Bearing Thioether Pendants for Enhanced Anticancer Drug Delivery.

Multi-Stimuli-Responsive Nanoparticles Formed of POSS-PEG for the Delivery of Boronic Acid-Containing Therapeutics.

Oxidation and temperature dual responsive polymers based on phenylboronic acid and N-isopropylacrylamide motifs

A facile strategy for constructing boron-rich polymer nanoparticles via a boronic acid-related reaction

Oxidation-Responsive Poly(Amino Ester)S Containing Arylboronic Ester and Self-Immolative Motif: Synthesis and Degradation Study

Controlled Dissociation of Polymeric Micelles in Response to Oxidative Stress

Synthesis of Poly(acyclic Orthoester)s: Acid‐Sensitive Biomaterials for Enhancing Immune Responses of Protein Vaccine

Self-Amplified Cascade Degradation and Oxidative Stress Via Rational Ph Regulation of Oxidation-Responsive Poly(ferrocene) Aggregates.

Multifunctional Oxidized Dextran as a Matrix for Stabilization of Octahedral Molybdenum and Tungsten Iodide Clusters in Aqueous Media

Biocompatible Nanoparticle Based on Dextran-b-Poly(L-lactide) Block Copolymer Formed by Flash Nanoprecipitation

Alternating Stealth Polymer Coatings Between Administrations Minimizes Toxic and Antibody Immune Responses Towards Nanomedicine Treatment Regimens.

Engineering Intracellular Delivery Nanocarriers And Nanoreactors From Oxidation-Responsive Polymersomes Via Synchronized Bilayer Crosslinking And Permeabilization Inside Live Cells

Redox-responsive Hyperbranched Poly(amido Amine) and Polymer Dots As a Vaccine Delivery System for Cancer Immunotherapy

Biodegradable nanoplatforms for antigen delivery: part I - state of the art review of polymeric nanoparticles for cancer immunotherapy

Scalable Dextran-Polypyrrole Nano-Assemblies with Photothermal/photoacoustic Dual Capabilities and Enhanced Biocompatibility.